🇺🇸 Amoxicillin and Clavulanic Acid in United States
67 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 67
Most-reported reactions
- Anaphylactic Reaction — 11 reports (16.42%)
- Therapeutic Product Cross-Reactivity — 11 reports (16.42%)
- Urticaria — 8 reports (11.94%)
- Pyrexia — 7 reports (10.45%)
- Pain — 6 reports (8.96%)
- Diarrhoea — 5 reports (7.46%)
- Dyspnoea — 5 reports (7.46%)
- Nausea — 5 reports (7.46%)
- Renal Failure Acute — 5 reports (7.46%)
- Anaemia — 4 reports (5.97%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Amoxicillin and Clavulanic Acid approved in United States?
Amoxicillin and Clavulanic Acid does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Amoxicillin and Clavulanic Acid in United States?
Maggiore Bellaria Hospital, Bologna is the originator. The local marketing authorisation holder may differ — check the official source linked above.